These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29395674)

  • 1. Specific muscle strength is reduced in facioscapulohumeral dystrophy: An MRI based musculoskeletal analysis.
    Marra MA; Heskamp L; Mul K; Lassche S; van Engelen BGM; Heerschap A; Verdonschot N
    Neuromuscul Disord; 2018 Mar; 28(3):238-245. PubMed ID: 29395674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy.
    Lassche S; Voermans NC; Schreuder T; Heerschap A; Küsters B; Ottenheijm CA; Hopman MT; van Engelen BG
    Muscle Nerve; 2021 Jan; 63(1):60-67. PubMed ID: 32959362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
    Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
    J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessement of quadriceps strength, endurance and fatigue in FSHD and CMT: benefits and limits of femoral nerve magnetic stimulation.
    Bachasson D; Temesi J; Bankole C; Lagrange E; Boutte C; Millet GY; Verges S; Levy P; Feasson L; Wuyam B
    Clin Neurophysiol; 2014 Feb; 125(2):396-405. PubMed ID: 24001968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle strength, quantity and quality and muscle fat quantity and their association with oxidative stress in patients with facioscapulohumeral muscular dystrophy: Effect of antioxidant supplementation.
    Wilson VD; Bommart S; Passerieux E; Thomas C; Pincemail J; Picot MC; Mercier J; Portet F; Arbogast S; Laoudj-Chenivesse D
    Free Radic Biol Med; 2024 Jul; 219():112-126. PubMed ID: 38574978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound Imaging of Muscle Contraction of the Tibialis Anterior in Patients with Facioscapulohumeral Dystrophy.
    Gijsbertse K; Goselink R; Lassche S; Nillesen M; Sprengers A; Verdonschot N; van Alfen N; de Korte C
    Ultrasound Med Biol; 2017 Nov; 43(11):2537-2545. PubMed ID: 28764967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD).
    Skalsky AJ; Abresch RT; Han JJ; Shin CS; McDonald CM
    Neuromuscul Disord; 2008 Nov; 18(11):873-80. PubMed ID: 18818077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
    Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
    Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy.
    Leung DG; Wang X; Barker PB; Carrino JA; Wagner KR
    Muscle Nerve; 2018 Jun; 57(6):958-963. PubMed ID: 29266323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle imaging in facioscapulohumeral muscular dystrophy, pattern and asymmetry of individual muscle involvement.
    Rijken NH; van der Kooi EL; Hendriks JC; van Asseldonk RJ; Padberg GW; Geurts AC; van Engelen BG
    Neuromuscul Disord; 2014 Dec; 24(12):1087-96. PubMed ID: 25176503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol.
    Lassche S; Ottenheijm CA; Voermans NC; Westeneng HJ; Janssen BH; van der Maarel SM; Hopman MT; Padberg GW; Stienen GJ; van Engelen BG
    BMC Neurol; 2013 Oct; 13():144. PubMed ID: 24119284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.
    Statland JM; McDermott MP; Heatwole C; Martens WB; Pandya S; van der Kooi EL; Kissel JT; Wagner KR; Tawil R
    Neuromuscul Disord; 2013 Apr; 23(4):306-12. PubMed ID: 23406877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of inflammatory lesions over 2 years in facioscapulohumeral muscular dystrophy.
    Dahlqvist JR; Poulsen NS; Østergaard ST; Fornander F; de Stricker Borch J; Danielsen ER; Thomsen C; Vissing J
    Neurology; 2020 Sep; 95(9):e1211-e1221. PubMed ID: 32611642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
    Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
    Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
    Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
    PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
    Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
    Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging correlates with electrical impedance myography in facioscapulohumeral muscular dystrophy.
    Hamel J; Lee P; Glenn MD; Burka T; Choi IY; Friedman SD; Shaw DWW; McCalley A; Herbelin L; Dimachkie MM; Lemmers R; van der Maarel SM; Barohn RJ; Tawil R; Statland JM
    Muscle Nerve; 2020 May; 61(5):644-649. PubMed ID: 31884698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
    Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
    Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.
    Mul K; Horlings CGC; Vincenten SCC; Voermans NC; van Engelen BGM; van Alfen N
    J Neurol; 2018 Nov; 265(11):2646-2655. PubMed ID: 30191320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
    Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
    Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.